Table 2.
Association between p53 protein expression and clinicopathological features in cervical cancer patients.
Character | Level | Low expression of p53 | High expression of p53 | p-value |
---|---|---|---|---|
Age | ≤60 | 45.0% | 55.0% | 0.176 |
>60 | 83.3% | 16.7% | ||
Histological type | G1 | 50% | 50% | 0.263 |
G2 | 43.8% | 56.3% | ||
G3 | 83.3% | 16.7% | ||
G4 | – | – | ||
Stage | I | 10.0% | 90.0% | 0.001** |
II | 72.7% | 27.3% | ||
III | 100% | 0% | ||
IV | – | – | ||
Lymph node metastasis | + | 66.7% | 53.8% | 0.426 |
− | 47.1% | 52.9% | ||
HPV16 E6 | + | 73.3% | 26.7% | 0.047* |
− | 27.3% | 72.7% |
*p < 0.05; **p < 0.01.